Stocks / EXPO

Exponent, Inc. (EXPO) Stock Analysis

Industrials · Engineering & Construction · NasdaqGS

Exponent, Inc. (EXPO) posted $536.76M in revenue for fiscal 2025 (up 3.5% year over year), at a 19.7% net margin, and has compounded revenue about 6.1%/yr over five years, per its SEC filings.

Data last refreshed August 2, 2026 from SEC filings · how we compute this

Price
$55.90
Market Cap
$2.71B
P/E Ratio
26.12
EPS
$2.14
Sector
Industrials
52-Week High
$81.95
52-Week Low
$51.91
Dividend Yield
2.13%

The analyst's take on Exponent, Inc.

Exponent, Inc. has grown revenue from $315.08M to $536.76M over the last 10 fiscal years, compounding about 6.1% a year. The most recent year was up 3.5%, so growth has cooled from its longer-run pace.

Net margin sits at 19.7%, down 1.3 points year over year.

At today's valuation the market is pricing in roughly 9.1% annual free-cash-flow growth — versus the 4.5% it actually delivered over the last five years, so the price already assumes a step-up from the recent record.

Synthesised from Exponent, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →

Exponent, Inc. revenue & earnings — last 10 fiscal years

Metric2016201720182020202120212022202320242025
Revenue$315.08M$347.80M$379.52M$417.20M$399.90M$466.27M$463.82M$497.19M$518.49M$536.76M
Gross profit
Net income$47.48M$41.30M$72.25M$82.46M$82.55M$101.20M$102.33M$100.34M$109.00M$106.01M
Net margin15.1%11.9%19.0%19.8%20.6%21.7%22.1%20.2%21.0%19.7%

Source: Exponent, Inc. SEC filings (10-K). 17 years of history available in the interactive view.

Exponent, Inc.: no obvious red flags in the filings

Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →

What growth is priced into EXPO stock?

At today's market cap of $2.71B, Exponent, Inc. is priced for free-cash-flow growth of about 9.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $122.34M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 4.5%/yr over the last five fiscal years and revenue 6.1%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →

Explore 17 years of Exponent, Inc. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track EXPO in your portfolio →

Exponent, Inc. financial history by metric

Compare Exponent, Inc. with peers

About Exponent, Inc.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

Exponent, Inc. — frequently asked questions

What is Exponent, Inc.'s revenue?

Exponent, Inc. (EXPO) reported revenue of $536.76M for fiscal year 2025, up 3.5% from the prior year, according to its SEC filings.

Is Exponent, Inc. profitable?

Yes. EXPO earned net income of $106.01M in fiscal 2025, a net margin of 19.7%.

What is EXPO's P/E ratio?

Exponent, Inc. trades at a price-to-earnings ratio of about 26.1 based on the latest data in our nightly-refreshed cache.

How fast is Exponent, Inc. growing?

EXPO's revenue grew at roughly 6.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Exponent, Inc. have?

As of fiscal year 2025, EXPO carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Exponent, Inc.'s market cap?

Exponent, Inc. (EXPO) has a market capitalization of about $2.71B, based on the latest data in our nightly-refreshed cache.

When does Exponent, Inc.'s fiscal year end?

EXPO's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

What growth is priced into EXPO stock?

At today's market cap of $2.71B, Exponent, Inc. is priced for free-cash-flow growth of about 9.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $122.34M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 4.5%/yr over the last five fiscal years and revenue 6.1%/yr, computed from its SEC filings.

Where does this data come from?

All figures are computed from Exponent, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals → · Check earnings quality → · Check share dilution →